{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T22:54:52Z","timestamp":1776898492324,"version":"3.51.2"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s11060-010-0375-6","type":"journal-article","created":{"date-parts":[[2010,9,10]],"date-time":"2010-09-10T03:29:51Z","timestamp":1284089391000},"page":"417-422","source":"Crossref","is-referenced-by-count":21,"title":["Opportunities for clinical research in meningioma"],"prefix":"10.1007","volume":"99","author":[{"given":"Michael A.","family":"Vogelbaum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Leland Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Linskey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minesh P.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,11]]},"reference":[{"issue":"1","key":"375_CR1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/jnnp.20.1.22","volume":"20","author":"D Simpson","year":"1957","unstructured":"Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20(1):22\u201339","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"375_CR2","first-page":"394","volume":"33","author":"T Kinjo","year":"1993","unstructured":"Kinjo T, al-Mefty O, Kanaan I (1993) Grade zero removal of supratentorial convexity meningiomas. Neurosurgery 33(3):394\u2013399","journal-title":"Neurosurgery"},{"issue":"10","key":"375_CR3","doi-asserted-by":"crossref","first-page":"936","DOI":"10.4065\/73.10.936","volume":"73","author":"S Stafford","year":"1998","unstructured":"Stafford S, Perry A, Suman V, Meyer F, Scheithauer B, Lohse C et al (1998) Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. Mayo Clin Proc 73(10):936\u2013942","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"375_CR4","first-page":"2046","volume":"85","author":"A Perry","year":"1999","unstructured":"Perry A, Scheithauer B, Stafford S, Lohse C, Wollan P (1999) \u201cMalignancy\u201d in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 85(9):2046\u20132056","journal-title":"Cancer"},{"issue":"5","key":"375_CR5","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3171\/jns.2000.92.5.0766","volume":"92","author":"J Kuratsu","year":"2000","unstructured":"Kuratsu J, Kochi M, Ushio Y (2000) Incidence and clinical features of asymptomatic meningiomas. J Neurosurg 92(5):766\u2013770","journal-title":"J Neurosurg"},{"issue":"6","key":"375_CR6","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1227\/01.NEU.0000188281.91351.B9","volume":"57","author":"E Claus","year":"2005","unstructured":"Claus E, Bondy M, Schildkraut J, Wiemels J, Wrensch M, Black P (2005) Epidemiology of intracranial meningioma. Neurosurgery 57(6):1088\u20131095","journal-title":"Neurosurgery"},{"issue":"5","key":"375_CR7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0090-3019(86)90259-4","volume":"26","author":"J J\u00e4\u00e4skel\u00e4inen","year":"1986","unstructured":"J\u00e4\u00e4skel\u00e4inen J (1986) Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol 26(5):461\u2013469","journal-title":"Surg Neurol"},{"issue":"3","key":"375_CR8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00006123-200003000-00008","volume":"46","author":"H Jung","year":"2000","unstructured":"Jung H, Yoo H, Paek S, Choi K (2000) Long-term outcome and growth rate of subtotally resected petroclival meningiomas: experience with 38 cases. Neurosurgery 46(3):567\u2013574","journal-title":"Neurosurgery"},{"issue":"2","key":"375_CR9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0360-3016(98)90008-6","volume":"15","author":"BJ Taylor","year":"1988","unstructured":"Taylor BJ, Marcus RJ, Friedman W, Ballinger WJ, Million R (1988) The meningioma controversy: postoperative radiation therapy. Int J Radiat Oncol Biol Phys 15(2):299\u2013304","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"375_CR10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF00172765","volume":"13","author":"R Miralbell","year":"1992","unstructured":"Miralbell R, Linggood R, de la Monte S, Convery K, Munzenrider J, Mirimanoff R (1992) The role of radiotherapy in the treatment of subtotally resected benign meningiomas. J Neurooncol 13(2):157\u2013164","journal-title":"J Neurooncol"},{"issue":"2","key":"375_CR11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0360-3016(97)00317-9","volume":"39","author":"K Condra","year":"1997","unstructured":"Condra K, Buatti J, Mendenhall W, Friedman W, Marcus RJ, Rhoton A (1997) Benign meningiomas: primary treatment selection affects survival. Int J Radiat Oncol Biol Phys 39(2):427\u2013436","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"375_CR12","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1080\/02688690701684246","volume":"21","author":"S Smith","year":"2007","unstructured":"Smith S, Boddu S, Macarthur D (2007) Atypical meningiomas: WHO moved the goalposts? Br J Neurosurg 21(6):588\u2013592","journal-title":"Br J Neurosurg"},{"issue":"2","key":"375_CR13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2990.2004.00621.x","volume":"31","author":"J Willis","year":"2005","unstructured":"Willis J, Smith C, Ironside J, Erridge S, Whittle I, Everington D (2005) The accuracy of meningioma grading: a 10-year retrospective audit. Neuropathol Appl Neurobiol 31(2):141\u2013149","journal-title":"Neuropathol Appl Neurobiol"},{"key":"375_CR14","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(06)70625-1","volume":"12","author":"M Riemenschneider","year":"2006","unstructured":"Riemenschneider M, Perry A, Reifenberger G (2006) Histological classification and molecular genetics of meningiomas. Lancet Neurol 12:1045\u20131054","journal-title":"Lancet Neurol"},{"issue":"5","key":"375_CR15","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.3171\/FOC\/2008\/24\/5\/E3","volume":"24","author":"B Pearson","year":"2008","unstructured":"Pearson B, Markert J, Fisher W, Guthrie B, Fiveash J, Palmer C et al (2008) Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria. Neurosurg Focus 24(5):E3","journal-title":"Neurosurg Focus"},{"issue":"1","key":"375_CR16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1227\/01.NEU.0000330399.55586.63","volume":"64","author":"M Aghi","year":"2009","unstructured":"Aghi M, Carter B, Cosgrove G, Ojemann R, Amin-Hanjani S, Martuza R et al (2009) Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 64(1):56\u201360","journal-title":"Neurosurgery"},{"issue":"9","key":"375_CR17","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s007010050398","volume":"141","author":"J Ayerbe","year":"1999","unstructured":"Ayerbe J, Lobato R, de la Cruz J, Alday R, Rivas J, G\u00f3mez P et al (1999) Risk factors predicting recurrence in patients operated on for intracranial meningioma. A multivariate analysis. Acta Neurochir (Wien) 141(9):921\u2013932","journal-title":"Acta Neurochir (Wien)"},{"issue":"3","key":"375_CR18","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0360-3016(03)00126-3","volume":"56","author":"J Flickinger","year":"2003","unstructured":"Flickinger J, Kondziolka D, Maitz A, Lunsford L (2003) Gamma knife radiosurgery of imaging-diagnosed intracranial meningioma. Int J Radiat Oncol Biol Phys 56(3):801\u2013806","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"375_CR19","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.3171\/foc.2003.14.5.5","volume":"14","author":"B Pollock","year":"2003","unstructured":"Pollock B (2003) Stereotactic radiosurgery for intracranial meningiomas: indications and results. Neurosurg Focus 14(5):E4","journal-title":"Neurosurg Focus"},{"issue":"1","key":"375_CR20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01050266","volume":"15","author":"J Goodwin","year":"1993","unstructured":"Goodwin J, Crowley J, Eyre H, Stafford B, Jaeckle K, Townsend J (1993) A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: a Southwest Oncology Group study. J Neurooncol 15(1):75\u201377","journal-title":"J Neurooncol"},{"key":"375_CR21","unstructured":"Grunberg SM, Rankin C, Townsend J, Ahmadi J, Feun L, Fredericks R, Russell C, Kabbinavar F, Barger GR, Stelzer KJ, Southwest Oncology Group, Eastern Cooperative Group (2001) Phase III double-blind randomized placebo-controlled study of mifepristone (RU) for the treatment of unresectable meningioma. In: Proceedings of the American Society of Clinical Oncology 20 (abstract 222)"},{"issue":"6","key":"375_CR22","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1215\/15228517-2009-010","volume":"11","author":"P Wen","year":"2009","unstructured":"Wen P, Yung W, Lamborn K, Norden A, Cloughesy T, Abrey L et al (2009) Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08). Neuro Oncol 11(6):853\u2013860","journal-title":"Neuro Oncol"},{"issue":"2","key":"375_CR23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11060-009-9948-7","volume":"96","author":"A Norden","year":"2010","unstructured":"Norden A, Raizer J, Abrey L, Lamborn K, Lassman A, Chang S et al (2010) Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma. J Neurooncol 96(2):211\u2013217","journal-title":"J Neurooncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-010-0375-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-010-0375-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-010-0375-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:19:46Z","timestamp":1559348386000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-010-0375-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["375"],"URL":"https:\/\/doi.org\/10.1007\/s11060-010-0375-6","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}